ABIVAX press release
ABIVAX announces the results of its Annual Ordinary and Extraordinary General Meeting of June 9, 2022.
All the resolutions proposed to the Meeting were adopted.
The resolutions presented by the Board of Directors were adopted and in particular, the approval of the financial statements for the year ended December 31, 2021, the compensation policy applicable to the Chairman of the Board of Directors, the Chief Executive Officer and the directors , as well as the delegations granted to the Board of Directors in financial matters.